申请人:Sirnaomics, Inc.
公开号:US20220054645A1
公开(公告)日:2022-02-24
The invention relates to the targeted delivery of therapeutic molecules to organs, tissues, and cells of humans and other mammals. The invention is directed to a chemical construct for delivering such therapeutic molecules and to methods of making and using the constructs.